FindTrial
Sign In

Nepafenac

DRUG12 trials

Sponsors

Innovative Medical, University of North Carolina, Chapel Hill, Asociación para Evitar la Ceguera en México, Hospital Juarez de Mexico, Frank A. Bucci, Jr., M.D.

Conditions

CataractCataract SurgeryCataractsCystoid Macular EdemaDiabetic RetinopathyInflamation ManagementInflammationIntraocular Pressure

Phase 2

Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation
TerminatedNCT00801905
Asociación para Evitar la Ceguera en MéxicoMacular Edema, Macular Thickening
Start: 2008-08-31End: 2009-03-31Updated: 2024-05-30
Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
CompletedNCT00900887
Hospital Juarez de MexicoDiabetic Retinopathy, Macular Edema
Start: 2008-04-30End: 2015-03-31Updated: 2015-03-20

Phase 4

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
CompletedNCT00377546
Innovative MedicalVitrectomy
Updated: 2008-09-25
Therapeutic Variables in Cataract Surgery
CompletedNCT00407017
Innovative MedicalCataract Surgery
Updated: 2007-08-21
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
CompletedNCT00494494
University of North Carolina, Chapel HillCystoid Macular Edema
Start: 2007-06-30End: 2008-04-30Updated: 2011-07-12
A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification
CompletedNCT01021761
Frank A. Bucci, Jr., M.D.Cataracts
Start: 2009-10-31End: 2010-01-31Updated: 2011-08-31
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%
CompletedNCT01310127
Toyos ClinicInflammation, Pseudophakia
Start: 2010-11-30End: 2011-05-31Updated: 2020-10-28
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
TerminatedNCT01939691
University of California, San FranciscoMacular Edema, Uveitis
Start: 2018-09-12End: 2020-03-31Updated: 2021-01-13
Effect of Nepafenac Eye Drops on Intraocular Pressure in Normal Eyes
CompletedNCT01995890
Dr T V Patel Eye InstituteIntraocular Pressure
Start: 2012-12-31End: 2013-04-30Updated: 2013-11-27
Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification
CompletedNCT02084576
Hospital Oftalmologico de BrasiliaCataract, Cystoid Macular Edema
Start: 2013-08-31End: 2014-02-28Updated: 2014-03-12
Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial
CompletedNCT03886779
Silverstein Eye CentersTreatment of Ocular Inflammation Associated With Cataract Surgery
Start: 2013-10-30End: 2019-03-31Updated: 2019-04-01

Unknown Phase

Comparison of Diclofenac vs. Nepafenac Ophthalmic Drops: Patient Comfort
NCT02506348
Wolfson Medical CenterInflamation Management, Pain Management, Post Surgical Management
Start: 2015-07-31Target: 30Updated: 2015-07-24

Related Papers

Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose
Ophthalmology and Therapy2019-09-244 citations
Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study
British Journal of Ophthalmology2014-11-1039 citations